These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35238482)

  • 1. Reciprocal Xp11.4p11.3 microdeletion/microduplication spanning USP9X, DDX3X, and CASK genes in two patients with syndromic intellectual disability.
    Catino G; Genovese S; Di Tommaso S; Orlando V; Petti MT; De Bernardi ML; Dallapiccola B; Novelli A; Ulgheri L; Piscopo C; Alesi V
    Am J Med Genet A; 2022 Jun; 188(6):1836-1847. PubMed ID: 35238482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo DDX3X missense variants in males appear viable and contribute to syndromic intellectual disability.
    Nicola P; Blackburn PR; Rasmussen KJ; Bertsch NL; Klee EW; Hasadsri L; Pichurin PN; Rankin J; Raymond FL; ; Clayton-Smith J
    Am J Med Genet A; 2019 Apr; 179(4):570-578. PubMed ID: 30734472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xp11.22 deletions encompassing CENPVL1, CENPVL2, MAGED1 and GSPT2 as a cause of syndromic X-linked intellectual disability.
    Grau C; Starkovich M; Azamian MS; Xia F; Cheung SW; Evans P; Henderson A; Lalani SR; Scott DA
    PLoS One; 2017; 12(4):e0175962. PubMed ID: 28414775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two females with mutations in USP9X highlight the variable expressivity of the intellectual disability syndrome.
    Au PYB; Huang L; Broley S; Gallagher L; Creede E; Lahey D; Ordorica S; Mina K; Boycott KM; Baynam G; Dyment DA
    Eur J Med Genet; 2017 Jul; 60(7):359-364. PubMed ID: 28377321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A hypomorphic inherited pathogenic variant in DDX3X causes male intellectual disability with additional neurodevelopmental and neurodegenerative features.
    Kellaris G; Khan K; Baig SM; Tsai IC; Zamora FM; Ruggieri P; Natowicz MR; Katsanis N
    Hum Genomics; 2018 Mar; 12(1):11. PubMed ID: 29490693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pure de-novo 5 Mb duplication at Xp11.22-p11.23 in a male: phenotypic and molecular characterization.
    Bonnet C; Grégoire MJ; Brochet K; Raffo E; Leheup B; Jonveaux P
    J Hum Genet; 2006; 51(9):815. PubMed ID: 16900295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xp11.22 duplications in four unrelated Chinese families: delineating the genotype-phenotype relationship for HSD17B10 and FGD1.
    Wang Q; Chen P; Liu J; Lou J; Liu Y; Yuan H
    BMC Med Genomics; 2020 May; 13(1):66. PubMed ID: 32381089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel Xp11.22 duplication involving HUWE1 in a male with syndromic intellectual disability and additional neurological findings.
    Santos-Rebouças CB; Boy R; Fernandes GNS; Gonçalves AP; Abdala BB; Gonzalez LGC; Dos Santos JM; Pimentel MMG
    Eur J Med Genet; 2023 Apr; 66(4):104716. PubMed ID: 36731745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotype-genotype correlations in 17 new patients with an Xp11.23p11.22 microduplication and review of the literature.
    Nizon M; Andrieux J; Rooryck C; de Blois MC; Bourel-Ponchel E; Bourgois B; Boute O; David A; Delobel B; Duban-Bedu B; Giuliano F; Goldenberg A; Grotto S; Héron D; Karmous-Benailly H; Keren B; Lacombe D; Lapierre JM; Le Caignec C; Le Galloudec E; Le Merrer M; Le Moing AG; Mathieu-Dramard M; Nusbaum S; Pichon O; Pinson L; Raoul O; Rio M; Romana S; Roubertie A; Colleaux L; Turleau C; Vekemans M; Nabbout R; Malan V
    Am J Med Genet A; 2015 Jan; 167A(1):111-22. PubMed ID: 25425167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duplication Xp11.22-p14 in females: does X-inactivation help in assessing their significance?
    Evers C; Mitter D; Strobl-Wildemann G; Haug U; Hackmann K; Maas B; Janssen JW; Jauch A; Hinderhofer K; Moog U
    Am J Med Genet A; 2015 Mar; 167A(3):553-62. PubMed ID: 25691408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel USP9X variant associated with syndromic intellectual disability in a female: A case study and review.
    Meira JGC; Magalhães BS; Ferreira IBB; Tavares DF; Kobayashi GS; Leão EKEA
    Am J Med Genet A; 2021 May; 185(5):1569-1574. PubMed ID: 33638286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in USP9X are associated with X-linked intellectual disability and disrupt neuronal cell migration and growth.
    Homan CC; Kumar R; Nguyen LS; Haan E; Raymond FL; Abidi F; Raynaud M; Schwartz CE; Wood SA; Gecz J; Jolly LA
    Am J Hum Genet; 2014 Mar; 94(3):470-8. PubMed ID: 24607389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exome and RNA-Seq analyses of an incomplete penetrance variant in USP9X in female-specific syndromic intellectual disability.
    Li D; March ME; Wang T; Merengwa V; Sertori Finoti L; Schrier Vergano SA; Hakonarson H; Bhoj EJ
    Am J Med Genet A; 2022 Jun; 188(6):1808-1814. PubMed ID: 35253988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel de novo DDX3X missense variant in a female with brachycephaly and intellectual disability: a case report.
    Moresco G; Costanza J; Santaniello C; Rondinone O; Grilli F; Prada E; Orcesi S; Coro I; Pichiecchio A; Marchisio P; Miozzo M; Fontana L; Milani D
    Ital J Pediatr; 2021 Mar; 47(1):81. PubMed ID: 33789733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in DDX3X Are a Common Cause of Unexplained Intellectual Disability with Gender-Specific Effects on Wnt Signaling.
    Snijders Blok L; Madsen E; Juusola J; Gilissen C; Baralle D; Reijnders MR; Venselaar H; Helsmoortel C; Cho MT; Hoischen A; Vissers LE; Koemans TS; Wissink-Lindhout W; Eichler EE; Romano C; Van Esch H; Stumpel C; Vreeburg M; Smeets E; Oberndorff K; van Bon BW; Shaw M; Gecz J; Haan E; Bienek M; Jensen C; Loeys BL; Van Dijck A; Innes AM; Racher H; Vermeer S; Di Donato N; Rump A; Tatton-Brown K; Parker MJ; Henderson A; Lynch SA; Fryer A; Ross A; Vasudevan P; Kini U; Newbury-Ecob R; Chandler K; Male A; ; Dijkstra S; Schieving J; Giltay J; van Gassen KL; Schuurs-Hoeijmakers J; Tan PL; Pediaditakis I; Haas SA; Retterer K; Reed P; Monaghan KG; Haverfield E; Natowicz M; Myers A; Kruer MC; Stein Q; Strauss KA; Brigatti KW; Keating K; Burton BK; Kim KH; Charrow J; Norman J; Foster-Barber A; Kline AD; Kimball A; Zackai E; Harr M; Fox J; McLaughlin J; Lindstrom K; Haude KM; van Roozendaal K; Brunner H; Chung WK; Kooy RF; Pfundt R; Kalscheuer V; Mehta SG; Katsanis N; Kleefstra T
    Am J Hum Genet; 2015 Aug; 97(2):343-52. PubMed ID: 26235985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and phenotypic findings in 34 novel Spanish patients with DDX3X neurodevelopmental disorder.
    Parra A; Pascual P; Cazalla M; Arias P; Gallego-Zazo N; San-Martín EA; Silván C; Santos-Simarro F; ; Nevado J; Tenorio-Castano J; Lapunzina P
    Clin Genet; 2024 Feb; 105(2):140-149. PubMed ID: 37904618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DDX3X mutations in two girls with a phenotype overlapping Toriello-Carey syndrome.
    Dikow N; Granzow M; Graul-Neumann LM; Karch S; Hinderhofer K; Paramasivam N; Behl LJ; Kaufmann L; Fischer C; Evers C; Schlesner M; Eils R; Borck G; Zweier C; Bartram CR; Carey JC; Moog U
    Am J Med Genet A; 2017 May; 173(5):1369-1373. PubMed ID: 28371085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three de novo DDX3X variants associated with distinctive brain developmental abnormalities and brain tumor in intellectually disabled females.
    Scala M; Torella A; Severino M; Morana G; Castello R; Accogli A; Verrico A; Vari MS; Cappuccio G; Pinelli M; Vitiello G; Terrone G; D'Amico A; ; Nigro V; Capra V
    Eur J Hum Genet; 2019 Aug; 27(8):1254-1259. PubMed ID: 30936465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of USP9X as a leukemia susceptibility gene.
    Sisoudiya SD; Mishra P; Li H; Schraw JM; Scheurer ME; Salvi S; Doddapaneni H; Muzny D; Mitchell D; Taylor O; Sabo A; Lupo PJ; Plon SE
    Blood Adv; 2023 Aug; 7(16):4563-4575. PubMed ID: 37289514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A microdeletion at Xq22.2 implicates a glycine receptor GLRA4 involved in intellectual disability, behavioral problems and craniofacial anomalies.
    Labonne JD; Graves TD; Shen Y; Jones JR; Kong IK; Layman LC; Kim HG
    BMC Neurol; 2016 Aug; 16():132. PubMed ID: 27506666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.